Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis
暂无分享,去创建一个
P. Fasching | A. Lophatananon | S. Lewis | W. Zheng | U. Menon | A. Gentry-Maharaj | K. Muir | G. Davey Smith | Sue-Kyung Park | C. Relton | Byoung-Gie Kim | Richard M. Martin | A. Walther | Boyoung Park | Jie Zheng | Ji-Yeob Choi | J. Yarmolinsky | Woo Yin Ling
[1] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[2] H. Risch,et al. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. , 1996, American journal of epidemiology.
[3] B. Henderson,et al. Hormonal carcinogenesis. , 2000, Carcinogenesis.
[4] R. Ness,et al. Cigarette Smoking and the Risk of Mucinous and Nonmucinous Epithelial Ovarian Cancer , 2002, Epidemiology.
[5] P. Dickman,et al. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. , 2002, American journal of epidemiology.
[6] V. Beral,et al. Long‐term effects of oral contraceptives on ovarian cancer risk , 2002, International journal of cancer.
[7] R. Bast,et al. Epithelial Ovarian Cancer , 2012 .
[8] L. Sobin,et al. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. , 2003, American journal of epidemiology.
[9] S. Ebrahim,et al. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.
[10] M. Goodman,et al. Active and passive tobacco smoking and the risk of borderline and invasive ovarian cancer (United States) , 2003, Cancer Causes & Control.
[11] E. Feuer,et al. SEER Cancer Statistics Review, 1975-2003 , 2006 .
[12] D. Whiteman,et al. Does smoking increase risk of ovarian cancer? A systematic review. , 2006, Gynecologic Oncology.
[13] I. Gram,et al. Cigarette smoking and risk of borderline and invasive epithelial ovarian cancer , 2008, International journal of cancer.
[14] J. Seidman,et al. Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors. , 2008, Archives of pathology & laboratory medicine.
[15] I. Shih,et al. Cystic and Adenofibromatous Clear Cell Carcinomas of the Ovary: Distinctive Tumors That Differ in Their Pathogenesis and Behavior: A Clinicopathologic Analysis of 122 Cases , 2009, The American journal of surgical pathology.
[16] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[17] A. Parwani. Cystic and Adenofibromatous Clear Cell Carcinomas of the Ovary: Distinctive Tumors That Differ in Their Pathogenesis and Behavior: A Clinicopathologic Analysis of 122 Cases , 2010 .
[18] B. Rosner,et al. Risk factors for epithelial ovarian cancer by histologic subtype. , 2010, American journal of epidemiology.
[19] I. Gram,et al. Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition , 2011, British Journal of Cancer.
[20] P. Elliott,et al. Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels , 2011, Circulation.
[21] D. Parkin. 2. Tobacco-attributable cancer burden in the UK in 2010 , 2011, British Journal of Cancer.
[22] S. Thompson,et al. Avoiding bias from weak instruments in Mendelian randomization studies. , 2011, International journal of epidemiology.
[23] Andy H. Lee,et al. Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies , 2012, PLoS medicine.
[24] Andy H. Lee,et al. Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies , 2012, The Lancet. Oncology.
[25] A. Al-Niaimi,et al. Epithelial ovarian cancer. , 2012, Obstetrics and gynecology clinics of North America.
[26] G. Rodriguez,et al. Ovarian cancer: etiology, risk factors, and epidemiology. , 2012, Clinical obstetrics and gynecology.
[27] B. Davidson,et al. Borderline ovarian tumours. , 2012, Best practice & research. Clinical obstetrics & gynaecology.
[28] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[29] Andrew D. Johnson,et al. A Genome-Wide Association Meta-Analysis of Circulating Sex Hormone–Binding Globulin Reveals Multiple Loci Implicated in Sex Steroid Hormone Regulation , 2012, PLoS genetics.
[30] Tanya M. Teslovich,et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.
[31] B. Kong,et al. Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis , 2012, Journal of Hematology & Oncology.
[32] J. Prat. New insights into ovarian cancer pathology. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[33] P. Hartge,et al. Ovarian cancer risk factors by histologic subtypes in the NIH‐AARP diet and health study , 2012, International journal of cancer.
[34] V. Hasselblad,et al. Oral Contraceptive Pills as Primary Prevention for Ovarian Cancer: A Systematic Review and Meta-analysis , 2013, Obstetrics and gynecology.
[35] R. Kurman. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[36] M. Pike,et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. , 2013, Endocrine-related cancer.
[37] A. Whittemore,et al. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies , 2013, Cancer Causes & Control.
[38] D. Alberts,et al. Dietary Intake and Ovarian Cancer Risk: A Systematic Review , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[39] P. Hartge,et al. Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. , 2014, Gynecologic oncology.
[40] Ross M. Fraser,et al. Defining the role of common variation in the genomic and biological architecture of adult human height , 2014, Nature Genetics.
[41] V. Beral,et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer , 2015, Nature Reviews Cancer.
[42] I. Gram,et al. Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[43] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[44] Andrew D. Johnson,et al. Nature Genetics Advance Online Publication Large-scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility and Brca1-mediated Dna Repair , 2022 .
[45] G. Davey Smith,et al. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.
[46] Ross M. Fraser,et al. Genetic studies of body mass index yield new insights for obesity biology , 2015, Nature.
[47] F. Clavel-Chapelon,et al. Reproductive and hormone‐related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort , 2015, International journal of cancer.
[48] Andrew D. Johnson,et al. Large-scale genomic analyses link reproductive ageing to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair , 2015, Nature Genetics.
[49] R. Cress,et al. Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer , 2015, Obstetrics and gynecology.
[50] Stephen Burgess,et al. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods , 2015, Statistics in medicine.
[51] A. Whittemore,et al. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. , 2016, International journal of epidemiology.
[52] A. McRae,et al. Identification of Common Genetic Variants Influencing Spontaneous Dizygotic Twinning and Female Fertility. , 2016, American journal of human genetics.
[53] Dennis J. Hazelett,et al. The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers , 2016, Cancer Epidemiology, Biomarkers & Prevention.
[54] G. Davey Smith,et al. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator , 2016, Genetic epidemiology.
[55] R. Bast,et al. Holland-Frei Cancer Medicine , 2016 .
[56] Qian Zhang,et al. The Association between Endometriosis, Tubal Ligation, Hysterectomy and Epithelial Ovarian Cancer: Meta-Analyses , 2016, International journal of environmental research and public health.
[57] N. Eriksson,et al. Genome-wide analysis identifies 12 loci influencing human reproductive behavior , 2016 .
[58] P. A. van den Brandt,et al. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[59] Yurii B. Shvetsov,et al. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. , 2016, International journal of epidemiology.
[60] Fernando Pires Hartwig,et al. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption , 2017, bioRxiv.
[61] G. Davey Smith,et al. Orienting the causal relationship between imprecisely measured traits using GWAS summary data , 2017, PLoS genetics.
[62] I. Gram,et al. Smoking and risk of ovarian cancer by histological subtypes: an analysis among 300 000 Norwegian women , 2016, British Journal of Cancer.
[63] P. O’Reilly,et al. Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels , 2018, Nature Communications.
[64] S. Lewis,et al. Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study , 2017, British Medical Journal.
[65] A. Morris,et al. Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism , 2017, Nature Communications.
[66] S. Jordan,et al. Epidemiology of epithelial ovarian cancer. , 2017, Best practice & research. Clinical obstetrics & gynaecology.
[67] Kconfab Investigators,et al. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer , 2017 .
[68] Kathleen R. Cho,et al. The disparate origins of ovarian cancers: pathogenesis and prevention strategies , 2016, Nature Reviews Cancer.
[69] N. Wentzensen,et al. Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research. , 2017, Journal of the National Cancer Institute.
[70] Helen E. Parkinson,et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog) , 2016, Nucleic Acids Res..
[71] J. Buring,et al. Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort Consortium. , 2017, Cancer research.
[72] J. Doherty,et al. Epidemiologic paradigms for progress in ovarian cancer research , 2017, Cancer Causes & Control.
[73] Lara E Sucheston-Campbell,et al. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer , 2017, Nature Genetics.
[74] E. Demerath,et al. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk , 2017, Nature Genetics.
[75] V. Beral,et al. Histological subtypes of ovarian cancer associated with parity and breastfeeding in the prospective Million Women Study , 2017, International journal of cancer.
[76] S. Lewis,et al. Causal Inference in Cancer Epidemiology: What Is the Role of Mendelian Randomization? , 2018, Cancer Epidemiology, Biomarkers & Prevention.
[77] M. Jarvelin,et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria , 2018, bioRxiv.
[78] Yurii B. Shvetsov,et al. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study , 2018, British Journal of Cancer.
[79] M. Munafo,et al. Causal effects of lifetime smoking on risk for depression and schizophrenia: Evidence from a Mendelian randomisation study , 2018 .
[80] Valeriia Haberland,et al. The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.
[81] Hormonal , 2020, Definitions.
[82] S. Larsson,et al. Is Type 2 Diabetes Causally Associated With Cancer Risk? Evidence From a Two-Sample Mendelian Randomization Study , 2020, Diabetes.
[83] C. Adams. A multivariable Mendelian randomization to appraise the pleiotropy between intelligence, education, and bipolar disorder in relation to schizophrenia , 2020, Scientific Reports.
[84] Peng-Hui Wang,et al. Subsequent Development of Epithelial Ovarian Cancer After Ovarian Surgery for Benign Ovarian Tumor: A Population-Based Cohort Study , 2020, Clinical epidemiology.
[85] Juan Wang,et al. PTEN/AKT/mTOR signaling mediates anticancer effects of epigallocatechin-3-gallate in ovarian cancer , 2020, Oncology reports.
[86] S. Tsavachidis,et al. Testing for causality between systematically identified risk factors and glioma: a Mendelian randomization study , 2020, BMC Cancer.